Soap Notes: | Main Cardiology Dermatology Endocrine Hematology GI Nephrology Neurology Pulmonary Rheumatology Herbal Therapy |
Megablastic Anemia
(Vitamin B –12
Deficiency – Pernicious Anemia)
S/O |
Assessment |
Plan |
||
Problem: S/O evidence |
Etiology |
Recommended Therapy |
Goals/Monitoring Parameters |
Patient Education |
Subjective: -Weakness -Sore Tongue -Peripheral neuropathy -Neurologic symptoms (tinnitus, neuritis, vertigo, and HA)
Objective: -Serum vit. B12 ß -MCV (macrocytic) Ý -MCHC (homochromic/ normochrmic) ß Û -Reticulocytes ß -RDW (variation) Ý -Hgb and Hct ß Schilling’s Test-evaluates Vit B12 absorption.
< 5% (+) for P. anemia. [Normal 15-50%) |
*1).Inability to absorb Vit B12 (at the distal ileum) -Reduced intrinisic factor -Reduced acid secretion/H2-receptor blockers -Occurs freq. In pts with: --Thyrotoxicosis --Hashimoto’s thyroiditis --Vitiligo --Rheumatoid Arthritis --Gastric cancer 2).B12 Deficiency: -Inadequate intake of B12 -Decreased absorption, transport,utilization --inherited atrophic gastropathy --Reduced intrinisic factor --gastrectomy (ilialsectomy) --Pancreatic insufficiency --Bacterial overgrowth in the intestine --Transcobalamin deficiency |
Vit. B12- important for hematopoiesis, maintanence of myelin
throughout CNS, production of epithelial cells.
Minimum Daily Requirement: 1-5 mcg/day vit. B-12 Daily lost: 1mcg/d Deficiency Symptoms develop: 3-4 yearsàBody storage: 2000-5000 mcg and
enterohepatic recirculation
Adults: IM: Vitamin
B12 (Cyanocobalamin) 100mcg IM QD x 2 weeks then 100mcg IM Qmonth indefinitely PO: Available for Pt w/ contraindication to Parenteral but requires HIGH
doses (500-1000mcg) not recommended due to lack of compliance and
efficacy.
IF D/C, reoccurance in 5 yrs |
Goals: Correct underlying cause Restore B12 levels Relieve Symptoms Restore Hgb, Hct Monitor: PO/IV Therapy Response— -Neurologic: Symptoms-improve within 24 hrs -Reticulocytes – normal by 5 days -Hct—normalized in 1-2months -Bone marrow-normoblastic w/in 48h -Hematologic parameters improvement in few days **Monitor CBC q3-6months to evaluate efficacy |
Regular Healthy Diet (meat and dairy) |
References:
Di Piro JT, et al. Pharmacotherapy, A Pathophysiologic Approach. 4th edition. Stamford, Appleton & Lange, Inc, 1999.L.Y. Young and M.A. Koda Kimble (eds): Applied Therapeutics: The Clinical Use of Drugs. 6th edition. Vancouver, Applied Therapeutics, Inc.,1995.Teresi ME, Kailis SG, Berbatis CG. Iron deficiency and Megaloblastic anemias. In: Textbook of Therapeutics. 6th Edition.